Literature DB >> 6407905

Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism.

M Borzio, R Caldara, F Borzio, V Piepoli, P Rampini, C Ferrari.   

Abstract

To further evaluate thyroid function in patients with liver disease, we have measured total and free T3 and T4, thyroxine binding globulin, basal and thyrotropin releasing hormone-stimulated thyrotropin and thyroglobulin antibodies in 33 patients with liver cirrhosis, in 22 with chronic hepatitis and in 30 healthy controls. All the patients but one were clinically euthyroid. T3, FT3, T3/thyroxine binding globulin and T4/thyroxine binding globulin ratios and thyrotropin after thyrotropin releasing hormone were significantly reduced, while FT4, thyroxine binding globulin and thyrotropin were significantly increased in liver cirrhosis. In chronic hepatitis group, FT3 and T3/thyroxine binding globulin ratio were significantly lower and thyroxine binding globulin and FT4 were higher than in healthy controls. The between patients comparison revealed a significantly lower T3, FT3, T3/thyroxine binding globulin and T4/thyroxine binding globulin ratios and delta thyrotropin in cirrhotics. Thyroglobulin antibodies were present at high titre only in two patients one of whom having evidence of Hashimoto's thyroiditis with subclinical hypothyroidism. The correlation coefficient between T4/thyroxine binding globulin ratio and FT4 were lower in patients than in controls. Furthermore an abnormal thyrotropin response to thyrotropin releasing hormone was shown in 10 cirrhotics and in four patients with chronic hepatitis. Serum T3 significantly correlated with serum bilirubin, albumin, and prothrombin time in both groups of patients. The present data confirm the existence of several abnormalities of thyroid function tests in patients with chronic liver disease, although showing that euthyroidism is almost always maintained, probably as a result of low-normal FT3 and high-normal FT4. Furthermore, T3 serum levels appear to parallel the severity of liver dysfunction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407905      PMCID: PMC1420033          DOI: 10.1136/gut.24.7.631

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  False neurotransmitters and hepatic failure.

Authors:  J E Fischer; R J Baldessarini
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

2.  Thyroid function and thyroid regulation in euthyroid men with chronic liver disease: evidence of multiple abnormalities.

Authors:  J R Green; E J Snitcher; N A Mowat; R P Ekins; L H Rees; A M Dawson
Journal:  Clin Endocrinol (Oxf)       Date:  1977-12       Impact factor: 3.478

3.  Alterations in circulating thyroid hormones and thyrotropin in hepatic cirrhosis: evidence for euthyroidism despite subnormal serum triiodothyronine.

Authors:  I J Chopra; D H Solomon; U Chopra; R T Young; G N Chua Teco
Journal:  J Clin Endocrinol Metab       Date:  1974-09       Impact factor: 5.958

4.  Increased serum thyroid hormone binding and decreased free hormone in chronic active liver disease.

Authors:  G C Schussler; F Schaffner; F Korn
Journal:  N Engl J Med       Date:  1978-09-07       Impact factor: 91.245

5.  Simplified, partially automated method for radioimmunoassay of human thyroid-stimulating, growth, luteinizing, and follicle stimulating hormones.

Authors:  W D Odell; P L Rayford; G T Ross
Journal:  J Lab Clin Med       Date:  1967-12

6.  Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis.

Authors:  S Nomura; C S Pittman; J B Chambers; M W Buck; T Shimizu
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

7.  High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease.

Authors:  F Bermudez; M I Surks; J H Oppenheimer
Journal:  J Clin Endocrinol Metab       Date:  1975-07       Impact factor: 5.958

8.  Thyroid hormones in alcoholic liver disease. Effect of treatment with 6-n-propylthiouracil.

Authors:  Y Israel; P G Walfish; H Orrego; J Blake; H Kalant
Journal:  Gastroenterology       Date:  1979-01       Impact factor: 22.682

9.  Direct immunoassay of triiodothyronine in human serum.

Authors:  P R Larsen
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

10.  Radioimmunoassay of human thyroxine-binding globulin (TBG).

Authors:  R P Levy; J S Marshall; N L Velayo
Journal:  J Clin Endocrinol Metab       Date:  1971-03       Impact factor: 5.958

View more
  15 in total

1.  Day-night variations in thyroid stimulating hormone and its relation with clinical status and metabolic parameters in patients with cirrhosis of the liver.

Authors:  Roni Atalay; Reyhan Ersoy; Aylin Bolat Demirezer; Fatma Ebru Akın; Sefika Burcak Polat; Bekir Cakir; Osman Ersoy
Journal:  Endocrine       Date:  2014-07-26       Impact factor: 3.633

2.  Relation of thyroid hormone abnormalities with subclinical inflammatory activity in patients with type 1 and type 2 diabetes mellitus.

Authors:  Arnaldo Moura Neto; Maria Candida Ribeiro Parisi; Sarah Monte Alegre; Elizabeth Joao Pavin; Marcos Antonio Tambascia; Denise Engelbrecht Zantut-Wittmann
Journal:  Endocrine       Date:  2015-06-07       Impact factor: 3.633

3.  Serum thyroid hormone levels in patients with fulminant hepatitis: usefulness of rT3 and the rT3/T3 ratio as prognostic indices.

Authors:  T Kano; T Kojima; T Takahashi; Y Muto
Journal:  Gastroenterol Jpn       Date:  1987-06

4.  Severity of alcoholic liver disease and markers of thyroid and steroid status.

Authors:  P Burra; J A Franklyn; D B Ramsden; E Elias; M C Sheppard
Journal:  Postgrad Med J       Date:  1992-10       Impact factor: 2.401

5.  Thyroid hormones alterations during acute liver failure: possible underlying mechanisms and consequences.

Authors:  Georgia Kostopanagiotou; Konstantinos Kalimeris; Iordanis Mourouzis; Konstantinos Kostopanagiotou; Nikolaos Arkadopoulos; Dimitrios Panagopoulos; Nikolaos Papoutsidakis; Aikaterini Chranioti; Agatha Pafiti; Danai Spanou; Vassilios Smyrniotis; Constantinos Pantos
Journal:  Endocrine       Date:  2009-06-19       Impact factor: 3.633

6.  Effect of Preeclampsia on Ultrastructure of Thyroid Gland, Hepatic Type 1 Iodothyronine Deiodinase, and Thyroid Hormone Levels in Rats.

Authors:  Yunlu Liu; Zhuping Xu; Yanqin Li; Wenyan Jiang; Ming Lan; Xiaojuan Xie; Yang Wang
Journal:  Biomed Res Int       Date:  2021-04-20       Impact factor: 3.411

7.  Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin.

Authors:  Debora Lucia Seguro Danilovic; Maria Cassia Mendes-Correa; Maria Cristina Chammas; Heverton Zambrini; Suemi Marui
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

8.  A 40-year-old woman who developed jaundice during therapy for thyrotoxicosis.

Authors:  Chukwuma Ogbonna Ekpebegh; Naomi Sharlene Levitt
Journal:  PLoS Med       Date:  2006-01-31       Impact factor: 11.069

9.  Putative abrogation impacts of Ajwa seeds on oxidative damage, liver dysfunction and associated complications in rats exposed to carbon tetrachloride.

Authors:  Noura M Mesalam; Sami Ali Aldhumri; Salah A Gabr; Marwa A Ibrahim; Asmaa K Al-Mokaddem; Abdel-Moneim Eid Abdel-Moneim
Journal:  Mol Biol Rep       Date:  2021-07-09       Impact factor: 2.316

Review 10.  Molecular functions of thyroid hormones and their clinical significance in liver-related diseases.

Authors:  Hsiang Cheng Chi; Cheng-Yi Chen; Ming-Ming Tsai; Chung-Ying Tsai; Kwang-Huei Lin
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.